BR112023014382A2 - Estrutura de transcrição gênica, sistema vetorial, método de edição da sequência do genoma e aplicação - Google Patents

Estrutura de transcrição gênica, sistema vetorial, método de edição da sequência do genoma e aplicação

Info

Publication number
BR112023014382A2
BR112023014382A2 BR112023014382A BR112023014382A BR112023014382A2 BR 112023014382 A2 BR112023014382 A2 BR 112023014382A2 BR 112023014382 A BR112023014382 A BR 112023014382A BR 112023014382 A BR112023014382 A BR 112023014382A BR 112023014382 A2 BR112023014382 A2 BR 112023014382A2
Authority
BR
Brazil
Prior art keywords
sequence
editing method
genome
gene transcription
application
Prior art date
Application number
BR112023014382A
Other languages
English (en)
Portuguese (pt)
Inventor
Shuanghong Peng
Yunpeng Sui
Original Assignee
Shuanghong Peng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shuanghong Peng filed Critical Shuanghong Peng
Publication of BR112023014382A2 publication Critical patent/BR112023014382A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/90—Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Management Or Editing Of Information On Record Carriers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112023014382A 2021-01-22 2021-12-01 Estrutura de transcrição gênica, sistema vetorial, método de edição da sequência do genoma e aplicação BR112023014382A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110089068.1A CN112708636A (zh) 2021-01-22 2021-01-22 基因转录框架、载体系统、基因组序列编辑方法及应用
PCT/CN2021/134710 WO2022156378A1 (zh) 2021-01-22 2021-12-01 基因转录框架、载体系统、基因组序列编辑方法及应用

Publications (1)

Publication Number Publication Date
BR112023014382A2 true BR112023014382A2 (pt) 2023-10-31

Family

ID=75550451

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023014382A BR112023014382A2 (pt) 2021-01-22 2021-12-01 Estrutura de transcrição gênica, sistema vetorial, método de edição da sequência do genoma e aplicação

Country Status (11)

Country Link
US (1) US20250263737A1 (https=)
EP (1) EP4282968A4 (https=)
JP (1) JP2024504592A (https=)
KR (1) KR20230135630A (https=)
CN (1) CN112708636A (https=)
AU (1) AU2021422067A1 (https=)
BR (1) BR112023014382A2 (https=)
CA (1) CA3206081A1 (https=)
MX (1) MX2023008635A (https=)
WO (1) WO2022156378A1 (https=)
ZA (1) ZA202308025B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112481259B (zh) * 2020-11-24 2022-09-16 南昌大学 两种甘薯U6基因启动子IbU6的克隆与应用
CN115044583A (zh) * 2022-03-21 2022-09-13 隋云鹏 用于基因编辑的rna框架和基因编辑方法
CN115312121B (zh) * 2022-09-29 2023-03-24 北京齐碳科技有限公司 靶基因位点检测方法、装置、设备及计算机存储介质

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2281050B1 (en) * 2008-04-14 2014-04-02 Sangamo BioSciences, Inc. Linear donor constructs for targeted integration
CN102080101B (zh) * 2010-11-25 2013-01-09 北京济福霖生物技术有限公司 一种定点整合外源基因的方法
WO2016030501A1 (en) * 2014-08-28 2016-03-03 Centre National De La Recherche Scientifique - Cnrs - Synthetic alu-retrotransposon vectors for gene therapy
US11339427B2 (en) * 2016-02-12 2022-05-24 Jumpcode Genomics, Inc. Method for target specific RNA transcription of DNA sequences
CN113286880A (zh) * 2018-08-28 2021-08-20 旗舰先锋创新Vi有限责任公司 调控基因组的方法和组合物
US20210340562A1 (en) * 2018-10-19 2021-11-04 Board Of Regents, The University Of Texas System Engineered long interspersed element (line) transposons and methods of use
JP7831937B2 (ja) * 2019-09-03 2026-03-17 クリエイト・メディシンズ，インコーポレーテッド ゲノム組込みのための方法および組成物
CN112210573B (zh) * 2020-10-14 2024-02-06 浙江大学 一种用基因编辑改造原代细胞的dna模板及定点插入方法

Also Published As

Publication number Publication date
EP4282968A4 (en) 2024-12-04
JP2024504592A (ja) 2024-02-01
CN112708636A (zh) 2021-04-27
US20250263737A1 (en) 2025-08-21
ZA202308025B (en) 2024-03-27
CA3206081A1 (en) 2022-07-28
AU2021422067A1 (en) 2023-09-07
KR20230135630A (ko) 2023-09-25
MX2023008635A (es) 2023-10-17
EP4282968A1 (en) 2023-11-29
WO2022156378A1 (zh) 2022-07-28

Similar Documents

Publication Publication Date Title
BR112023014382A2 (pt) Estrutura de transcrição gênica, sistema vetorial, método de edição da sequência do genoma e aplicação
Petri et al. CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells
Hartenian et al. Feedback to the central dogma: cytoplasmic mRNA decay and transcription are interdependent processes
Hwang et al. Molecular mechanisms of circular RNA translation
Silva et al. TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells
Nunes et al. Emerging roles of tRNAs in RNA virus infections
Chen et al. RNA methylation and diseases: experimental results, databases, Web servers and computational models
Donovan et al. Rapid RNase L–driven arrest of protein synthesis in the dsRNA response without degradation of translation machinery
Peccarelli et al. Regulation of natural mRNAs by the nonsense-mediated mRNA decay pathway
Del Campo et al. Secondary structure across the bacterial transcriptome reveals versatile roles in mRNA regulation and function
Khoddami et al. Identification of direct targets and modified bases of RNA cytosine methyltransferases
Bachman et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Merrikh et al. Replication–transcription conflicts in bacteria
Jungfleisch et al. A novel translational control mechanism involving RNA structures within coding sequences
Breuer et al. What goes around comes around: Artificial circular RNAs bypass cellular antiviral responses
Wang et al. Cell-to-cell variation in defective virus expression and effects on host responses during influenza virus infection
Jäger et al. An archaeal sRNA targeting cis-and trans-encoded mRNAs via two distinct domains
Xiong et al. N1-methyladenosine formation, gene regulation, biological functions, and clinical relevance
Kuo et al. Inhibition of avian influenza A virus replication in human cells by host restriction factor TUFM is correlated with autophagy
Cauldwell et al. Unstable polymerase-nucleoprotein interaction is not responsible for avian influenza virus polymerase restriction in human cells
Yakhnin et al. NusG-dependent RNA polymerase pausing and tylosin-dependent ribosome stalling are required for tylosin resistance by inducing 23S rRNA methylation in Bacillus subtilis
Forero et al. The 1918 influenza virus PB2 protein enhances virulence through the disruption of inflammatory and Wnt-mediated signaling in mice
Zhang et al. Integration analysis of miRNA and mRNA expression profiles in swine testis cells infected with Japanese encephalitis virus
Gao et al. Integrated analysis of microRNA-mRNA expression in A549 cells infected with influenza A viruses (IAVs) from different host species
Landeras-Bueno et al. Chemical genomics identifies the PERK-mediated unfolded protein stress response as a cellular target for influenza virus inhibition